Helen Ye

RA & PV Director at Accestra Consulting 

  • Ms. Ye has been dedicated to regulatory affairs consulting for 15 years with a Pharmacy degree from Zhejiang University, China. 
  • She is experienced in regulatory compliance of China market access & post-marketing maintenance of pharmaceutical products, providing insightful and customised solutions to international pharmaceutical companies and government institutions. 
  • She leads the registration team to plan, develop and implement compliance strategies for top pharma clients and has a successful track record for obtaining market approval for drug products, APIs, Excipients, Packaging Materials, medical devices and other products.
  • Ms. Ye has a strong communication network with Chinese authorities (e.g. NMPA and CDE) and industry experts in China. 
  • To learn more about Helen or Accestra Consulting, please visit their website at www.accestra.com
  • Next: 23-24 Apr 2024 Live online
  • Also: 8-9 Jul 2024 Live online
  • Also: 8-9 Oct 2024 Live online

Understanding Pharmacovigilance Regulations in APAC

New for 2024

Live online

Pharmacovigilance regulations in Asia are dynamic and fast-changing. As the Asia-Pacific region becomes increasingly important for pharmaceutical companies, it's vital to ensure compliance and safety by staying informed of the latest regulatory developments.

  • 6 CPD hours Focused
  • Presented by Helen Ye